Becton, Dickinson and Company (NYSE:BDX) EVP Sells $105,570.00 in Stock

Becton, Dickinson and Company (NYSE:BDX) EVP Richard Byrd sold 459 shares of the stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $230.00, for a total value of $105,570.00. Following the transaction, the executive vice president now owns 6,952 shares in the company, valued at $1,598,960. This trade represents a 6.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Richard Byrd also recently made the following trade(s):

• On Wednesday, March 12th, Richard Byrd sold 1,940 shares of Becton, Dickinson and Company stock. The shares were sold at an average price of $224.91, for a total transaction of $436,325.40.

Becton, Dickinson and Company Trading Down 0.5 %

BDX opened at $230.63 on Friday. The firm has a market capitalization of $66.22 billion, a price-to-earnings ratio of 38.31, a PEG ratio of 1.63 and a beta of 0.35. Becton, Dickinson and Company has a one year low of $218.75 and a one year high of $251.99. The business has a 50 day simple moving average of $232.58 and a two-hundred day simple moving average of $232.04. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.13 and a quick ratio of 0.63.

Becton, Dickinson and Company (NYSE:BDX) last announced its quarterly earnings results on Wednesday, February 5th. The medical instruments supplier reported $3.43 EPS for the quarter, topping analysts’ consensus estimates of $3.00 by $0.43. Becton, Dickinson and Company had a return on equity of 15.74% and a net margin of 8.47%. Analysts predict that Becton, Dickinson and Company will post 14.43 EPS for the current year.

Becton, Dickinson and Company Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 10th will be issued a dividend of $1.04 per share. The ex-dividend date is Monday, March 10th. This represents a $4.16 dividend on an annualized basis and a dividend yield of 1.80%. Becton, Dickinson and Company’s dividend payout ratio (DPR) is 69.10%.

Becton, Dickinson and Company announced that its board has authorized a share buyback program on Tuesday, January 28th that allows the company to repurchase 10,000,000 outstanding shares. This repurchase authorization allows the medical instruments supplier to repurchase shares of its stock through open market purchases. Shares repurchase programs are generally a sign that the company’s board of directors believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several research firms recently commented on BDX. Barclays increased their target price on shares of Becton, Dickinson and Company from $278.00 to $279.00 and gave the company an “overweight” rating in a report on Friday, February 14th. StockNews.com raised Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a research note on Wednesday, March 5th. Finally, Piper Sandler increased their target price on Becton, Dickinson and Company from $275.00 to $280.00 and gave the company an “overweight” rating in a report on Tuesday, January 28th. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $278.29.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the business. Bank of Jackson Hole Trust purchased a new stake in Becton, Dickinson and Company in the fourth quarter worth about $25,000. Sierra Ocean LLC purchased a new position in Becton, Dickinson and Company during the fourth quarter valued at $29,000. REAP Financial Group LLC boosted its holdings in Becton, Dickinson and Company by 75.3% in the fourth quarter. REAP Financial Group LLC now owns 128 shares of the medical instruments supplier’s stock worth $29,000 after acquiring an additional 55 shares in the last quarter. Picton Mahoney Asset Management grew its stake in shares of Becton, Dickinson and Company by 61.4% in the fourth quarter. Picton Mahoney Asset Management now owns 142 shares of the medical instruments supplier’s stock worth $32,000 after acquiring an additional 54 shares during the last quarter. Finally, Hopwood Financial Services Inc. purchased a new position in shares of Becton, Dickinson and Company in the 4th quarter worth about $39,000. 86.97% of the stock is currently owned by institutional investors.

Becton, Dickinson and Company Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.